key: cord-0067575-vt8woseu
authors: Golshani, Shiva; Ali Faramarzi, Mohammad
title: Expected Impact of Biosimilars on the Pharmaceutical Companies
date: 2021-09-03
journal: Iran J Med Sci
DOI: 10.30476/ijms.2021.92314.2356
sha: d25ae7dca0e55785d5ff79de0c71f45bddf62c9b
doc_id: 67575
cord_uid: vt8woseu

nan

long-term benefits of the product. 12 The biosimilar market is currently controlled by a number of issues such as patent expiration of biological drugs, lower prices, the rise of chronic diseases, and cost-saving policies by governments. Considering the above-mentioned topics, the market is expected to have a fast growth during 2021-2026. With the uncertainties in the state of COVID-19, the direct, as well as the indirect influences of the pandemic on different industries, should be also continuously evaluated. 13 

Why biosimilar are important for patients

An overview of biosimilars

Biosimilars-why terminology matters

What are biosimilars and are they important?

European Union

Biosimilars in the EU

The Development Pathway for Biosimilar Biotherapeutics

Biosimilars 2020 year in review

None declared.